Severe rosacea in a patient on infliximab for ulcerative colitis: pathophysiological considerations

Acta Derm Venereol. 2009;89(5):522-3. doi: 10.2340/00015555-0681.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Biopsy
  • Colitis, Ulcerative / drug therapy*
  • Dermatologic Agents / therapeutic use
  • Doxycycline / therapeutic use
  • Drug Therapy, Combination
  • Gastrointestinal Agents / adverse effects*
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Propranolol / therapeutic use
  • Rosacea / chemically induced*
  • Rosacea / drug therapy
  • Rosacea / pathology
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Gastrointestinal Agents
  • Propranolol
  • Infliximab
  • Doxycycline